ResMed Inc. RMD
NYSE
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -3.34% | 2.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.34% | 2.25% | |||
| Cost of Revenue | -9.71% | 11.56% | |||
| Gross Profit | 1.02% | -3.26% | |||
| SG&A Expenses | -3.12% | 4.85% | |||
| Depreciation & Amortization | -- | -1.57% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.88% | 9.32% | |||
| Operating Income | 9.08% | -10.68% | |||
| Income Before Tax | 13.71% | -5.60% | |||
| Income Tax Expenses | 33.08% | -12.40% | |||
| Earnings from Continuing Operations | 9.12% | -3.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.12% | -3.84% | |||
| EBIT | 9.08% | -10.68% | |||
| EBITDA | 9.03% | -12.20% | |||
| EPS Basic | 10.44% | -3.42% | |||
| Normalized Basic EPS | 8.69% | -7.74% | |||
| EPS Diluted | 10.49% | -3.55% | |||
| Normalized Diluted EPS | 8.57% | -7.67% | |||
| Average Basic Shares Outstanding | -1.19% | -0.44% | |||
| Average Diluted Shares Outstanding | -1.08% | -0.51% | |||
| Dividend Per Share | 10.00% | 0.00% | |||
| Payout Ratio | 0.00% | 0.04% | |||